Global Apheresis Equipment Market to Reach US$2.3 bn by 2018

The global apheresis equipment market is led by companies such as Asahi Kasei Kuraray Medical Co., Ltd., B. Braun Melsungen AG, Hemacare Corporation, Haemonetics Corp., and Fenwal, Inc. The moderately consolidated global apheresis equipment market is likely to witness further consolidation in the coming years as key players aim to expand their geographical reach and product catalog. Collaborative research efforts and joint development of new product lines is another popular stratagem employed by many key players in the apheresis equipment market.

According to Transparency Market Research, the global apheresis equipment market is set to garner annual revenue of US$1.8 bn by the end of 2016. The annual revenue figure is further expected to rise to US$2.3 bn by the end of 2018.

Asia Pacific Set to Challenge North America’s Dominance

Geographically, North America is the leading contributor to the global market for apheresis equipment. The availability of advanced medical technology and the widespread awareness about the benefit of apheresis in North America are crucial to ensuring sustained growth of the region’s apheresis equipment market. North America held a share of more than 50% in the global apheresis equipment market in 2011, but its share is likely to drop to 44.4% by 2018.

The Asia Pacific market for apheresis equipment is expected to exhibit robust growth over the same period, with a CAGR of 13.49% expected from 2012 to 2018. Though the North America market for apheresis equipment will remain the leading contributor till the end of the forecast period, the investment potential of Asia Pacific is likely to be exploited by key players in the global market, facilitating its rise as a lucrative investment destination for the apheresis equipment industry.

By procedure, plasmapheresis comprises the leading segment of the global apheresis equipment market, holding a majority share of 59.22% in 2011. Despite an expected decline in its market share over the forecast period, plasmapheresis is expected to retain its majority share in the global apheresis equipment market. Photopheresis is another leading segment of the apheresis equipment market and is expected to hold a share of 24.4% in the global market by the end of 2018.

Improving Healthcare Infrastructure in Emerging Countries Drives Demand for Apheresis Equipment

One of the key drivers for the global apheresis equipment market is the steady progress exhibited by the healthcare sector in dynamic emerging economies. The growing awareness about blood donation in urban areas in the developing world has been crucial for the apheresis equipment market, as it has led to the establishment of flourishing blood bank networks and has thus helped provide the infrastructure needed for apheresis.

The increasing therapeutic use of plasma and platelets, which are used in the treatment or management of several diseases, is a crucial driver for the global apheresis equipment market. Plasmapheresis is commonly used in the treatment of several autoimmune diseases, while platelets are vital in managing diseases such as leukemia, the treatment for which damages the patient’s bone marrow. The rising prevalence of such conditions is likely to remain a key driver for the global apheresis equipment market in the coming years.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=871

High Costs, Risk of Complications Restrict Demand for Apheresis Procedures

One of the key restraints on the global apheresis equipment is the high cost of apheresis procedures. This factor is particularly influential in developing countries, where the absence of adequate reimbursement schemes has left the average consumer at a disadvantage. There is also a lack of trained personnel to operate apheresis equipment in emerging countries, which has emerged as a significant constraining factor.

The risk of contracting diseases through apheresis is one that can’t be denied. This, in addition to the risk of blood pressure complications due to fluctuations in the rate of fluid transfer, has been instrumental in restricting the demand for apheresis. Even though such complications are extremely rare in sophisticated facilities and treatable, they have had a significant negative impact on patient confidence.

The information in this preview comes from a Transparency Market Research report titled ‘Apheresis Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018.’

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: